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Fatigue in inflammatory arthritis 
Authors: Emma Dures, Fiona Cramp, Kate Hackett and Jette Primdahl 
Introduction  
This paper on fatigue in inflammatory arthritis (IA) is informed by research evidence and clinical 
practice. The conditions covered include rheumatoid arthritis (RA), psoriatic arthritis (PsA), 
spondyloarthritis (axSpA) (including ankylosing spondylitis (AS)), systemic lupus erythematosus (SLE) 
and primary Sjogren syndrome (pSS).  The authors professional backgrounds are physiotherapy (FC), 
psychology (ED), occupational therapy (KH) and nursing (JP). While we recognise that fatigue is a 
symptom that can affect people at all ages and with a range of musculoskeletal conditions, the focus 
in this paper is on adults with IA, SLE and pSS as these are our areas of expertise. We are interested in 
fatigue because it is common in IA and often described by those affected as their most problematic 
symptom.1  
 
Due to differences in definitions and measures, fatigue prevalence estimates vary from around 40% 
to over 80%.2 3 An international study of >6,000 people with IA found that one out of every two was 
severely fatigued, defined as scoring ≤35 on the SF-36 Vitality Scale.4 In RA, research has established 
that fatigue is present on most days for most people, with >70% reporting levels like those seen in 
Chronic Fatigue Syndrome, although the causes and the consequences may be distinct.5 6 A study 
based on two UK cohorts found that over 80% of people with RA had clinically relevant fatigue (Visual 
Analogue Scale (VAS) ≥20 mm) and over 50% had high levels of fatigue (VAS) ≥50 mm).7 Research in 
AS estimates the figure to be 53% - 65%,8 9 while research in SLE has put the figure at 67% - 90%.10-12 
In a study with people with pSS, 86% rated fatigue as the most important symptom to address.13 In 
people with PsA, moderate fatigue has been estimated to affect 49.5% and severe fatigue in 28.7%.14 
Recently, authors in Denmark conducted a cross sectional survey with 488 people with RA, PsA, and 
axSpA.  Although the study population were a clinically stable group with low disease activity and few 
disease-related treatment changes, 61% reported that they were affected by fatigue.15 These high 
levels of fatigue can be chronic. A Dutch study using the fatigue subscale of the Checklist Individual 
Strength (CIS) concluded that 40% of people with RA experienced persistent severe fatigue over a one-
year period, based on a validated cut-off score of ≥35.16 17   
 
In this paper, we start by focusing on the perspective of people living with IA and fatigue, including 
the experiential nature of the symptom and its impact on realms of daily life. We then present current 
conceptual models of mechanisms and factors that may cause and maintain fatigue, both within and 
between individuals. Next, we address fatigue measurement and modes of assessment, which is an 
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integral aspect of management and evaluating support provision. This leads to a review of the research 
evidence for non-pharmacological interventions to reduce fatigue severity and impact. Finally, we 
consider implementation of this evidence and an inter-disciplinary perspective on fatigue 
management in clinical practice. This includes practical tools and techniques.  
 
Living with fatigue 
Qualitative studies have explored the experience of living with fatigue in people with IA. They perceive 
fatigue as an overwhelming problem which can have a greater impact on their lives than pain.18-22 
Most of the research has focused on people with RA, and in 2019 these findings were brought together 
in a qualitative meta-synthesis23 of published studies.20 24-28 The systematic interpretive analysis 
identified an overall theme of ‘a vicious circle of an unpredictable symptom’. Four interconnected 
subthemes were: ‘being alone with fatigue’, ‘time as a challenge’, ‘language as a tool for increased 
understanding’, and ‘strategies to manage fatigue’. People with RA reported that their fatigue is 
difficult to control, with considerable consequences for every aspect of their daily lives. They explain 
that their RA-related fatigue is unearned and different to the tiredness or exhaustion experienced 
prior to diagnosis.  People describe how their fatigue is unpredictable and how it varies in severity, 
duration, frequency and intensity.  
 
People with IA have described physical, cognitive, emotional and social experiences of fatigue.28 The 
physical impact of fatigue can create a barrier to physical activity; with the body feeling heavy and 
unwell. Fatigue can also impact cognitive abilities, making it difficult to learn, focus, solve problems 
and engage with others. The emotional impact of fatigue has been experienced as frustration, 
hopelessness, fear, reduced motivation, lack of patience and exhaustion.  Socially, fatigue can restrict 
people’s ability to fulfil social roles in the family, in the wider social network, at work and in relation 
to leisure activities.  
 
The impact of fatigue can lead to loneliness when people with the symptom find it hard to socialise. 
Often, they try not to show that they are fatigued when in company or they avoid social contact 
completely and try to manage on their own. Even in consultations with rheumatologists and health 
professionals, their fatigue is rarely addressed; consequently, people can feel left alone to cope with 
the challenge.23 For many, it can be hard to ask for help and they do not wish to feel dependent on 
other people. Time becomes a challenge as managing their fatigue can mean that people need to take 
breaks during the day, with tasks often taking longer and requiring more effort than pre-diagnosis. 
People with RA-related fatigue feel that those without arthritis do not understand the tremendous 
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impact the invisible symptom has on their lives. As a result, they can be very conscious about the 
words they use to describe their fatigue when they talk to other people to help convey the full meaning 
and impact.23 
 
Living with fatigue has been less researched in people with other types of inflammatory arthritis, 
compared to RA. However, there are a few studies which have included the experiences of people 
with AS, PsA, and SLE.20 29 30 Descriptions of fatigue by people with AS are like those of people with RA, 
including feeling ‘tired’, ‘exhausted’, ‘worn out’ or ‘wiped out’, with fatigue leading to cognitive 
problems such as difficulty concentrating and being ‘too tired to think’. Like people with RA, they 
describe variations in fatigue over the course of a day.  Fatigue is often worse in the evening, but 
people can also wake up feeling fatigued.20 People with AS identify various factors which influence 
their fatigue, such as older age, lack of sleep, low-mood, night-time pain, depression, lack of 
concentration, side effects from medication, work commitments and the unpredictability of the 
condition. People with PsA also experience ‘unstoppable and far reaching fatigue’ which is different 
from normal tiredness.30 Their fatigue is linked to lack of motivation, loss of appetite and bodily pain.30 
People with SLE use similar words to describe their fatigue (‘worn out’, ‘lack of energy’, ‘exhaustion’ 
and ‘not wanting to do anything’) and they also find that the frequency and severity of their fatigue 
varies from day to day.29 People with SLE describe the physical consequence of fatigue as ‘feeling 
weak’ while the emotional impact concern mood swings, irritability, helplessness, anger, anxiety, 
tearfulness and feeling miserable. In their view, fatigue is associated with depression and cognitive 
difficulties with concentration, short-term memory, comprehension and the inability to think clearly. 
Fatigue limits or prevents activities in the home as well as leisure activities and restricted social 
relationships with friends and family.29  
 
IA-related fatigue affects employment, including productivity and ability to work. People often find 
that employers and colleagues have a limited understanding of their symptom.29 31-34 They try to take 
breaks and relax during the day, plan and prioritise, ask for help or divide tasks over several days to 
match their energy level.23 35 Even with some strategies in place, they report sometimes needing a full 
day per week to recover from activities that take energy. Overall, IA-related fatigue is experienced as 
a challenging symptom, which affects all areas of people’s daily lives. 
 
Evidence of mechanisms and models of fatigue in IA 
As we have seen from the evidence on living with fatigue, it is rare for patients to experience 
professional support for their fatigue.24 36 One possible reason for the lack of dialogue about fatigue 
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in IA is limited understanding of the mechanisms involved. Research has investigated the role of 
potential factors, including physical functioning, psychological functioning, medical status, 
comorbidities and symptoms, and demographic factors, such as age and gender. The results are 
equivocal, although there is growing consensus that psychosocial variables are influential.37 
 
In a study examining the physical and psychosocial correlates of fatigue in RA, the authors found that 
those with severe fatigue scored worse on all the psychosocial items that were measured, compared 
to those without severe fatigue. This included pain severity, role functioning, depressive mood, self-
efficacy, worry, helplessness and non-restorative sleep.5 Predictors of levels of fatigue in people with 
RA have also been examined using Leventhal's Common-Sense Model (CSM).38 The CSM states that 
cognitive representations of an illness/health condition influence how people cope, which then affects 
their health outcomes.  Data were collected from 114 people with RA (73.7% women) at baseline and 
one year later.38 This information included employment status, pain, impact of disability, sleep 
disruption frequency, depressed mood, perceptions of the consequences of RA, arthritis self-efficacy 
and attempts to manage RA by praying/hoping. The researchers found that a baseline perception that 
RA has severe consequences and is uncontrollable predicted greater fatigue after one year but that 
this relationship was not mediated by praying or hoping.39 There is further support for the role of 
psychosocial variables in pSS-related fatigue. In a study which examined cross-sectional data from 608 
patients from the United Kingdom Primary Sjögren’s Syndrome Registry, pain, depression and daytime 
sleepiness scores were closely associated with physical and mental fatigue (all p ≤ 0.0001). These 
effects were observed even after adjustment for comorbidities associated with fatigue or medications 
associated with drowsiness.40  
 
Hewlett et al. propose a conceptual model that includes three domains, each of which could 
contribute to fatigue in RA.19 First, disease-related factors such as inflammation, anaemia and cortisol 
response can play a part. Second, cognitive, emotional and behavioural factors, such as depression, 
health beliefs, low mood and activity patterns, can be involved. Third, contextual factors might be 
salient. These range from managing co-morbidities, to work and caring responsibilities. Any 
combination of these factors may predict, trigger or maintain fatigue. Over time, this combination 
may vary in response to changes in an individual’s RA symptoms and treatment, their psychological 
well-being or contextual factors, such as circumstances at home or work. The concept of complex 
factors influencing fatigue is supported by a recent systematic review in which the authors proposed 
a network model, encompassing multiple and mutually interacting biological, psychological and social 
factors.37 Findings from the systematic review indicated correlations of fatigue with physical disability, 
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poor mental well-being, pain, sleep disturbance, depression and anxiety. For the most part, these 
correlations remained significant in multivariate analyses, suggesting partly independent influences 
on fatigue and differences between individuals. This network model assumes that relationships 
between the biopsychosocial factors are dynamic and reciprocal, with mutually influencing pathways. 
A second assumption is that individuals differ in relation to the factors involved in their fatigue, as well 
as in the importance of both the weight of these factors and the strength of the relationships between 
these factors. Like Hewlett et al.’s conceptual model, the network model supports the idea that fatigue 
is not a single construct but rather a multidimensional concept. There is also qualitative evidence to 
support the idea of individual differences in the causes of fatigue, including a study with ten people 
with AS who completed a seven-day diary and participated in a semi-structured interview to explore 
their fatigue. While descriptions of the symptom were similar between individuals, perceived causes 
of fatigue varied. They included stress, depression, pain, weather, poor sleep and work.41  
 
While these conceptual propositions seems logical and comprehensive,19 37 a systematic review of 
epidemiological studies investigating fatigue determinants in RA only identified elements from the 
cognitive, emotional, behavioural and the contextual domains; and a lack of associations with 
biomedical factors.42 Some health professionals may be surprised at the absence of evidence to 
support the relationship between fatigue in RA and levels of inflammation. However, data from 
epidemiological research has found that rates of fatigue are similar between RA and some types of 
non-inflammatory arthritis, such as osteoarthritis (OA).43 In addition, fatigue can be a significant 
symptom in people with RA even when there is no or minimal disease activity. In the UK’s RA biologics 
register, 62% reported clinically relevant fatigue at one year despite reaching remission.44 
 
Overall, the evidence about causes of fatigue in IA offers a mixed picture. Fatigue is likely to be 
multidimensional and driven by factors that differ between and within individuals over time. It 
suggests that we should focus research on individual-specific networks of biopsychosocial factors that 
maintain fatigue and we should tailor interventions that target the influencing factors most relevant 
to that person. This is important because even though the mechanisms are not fully understood, there 
is evidence that the associations of fatigue with factors that are amenable to behaviour change are 
moderate to high.37 
 
Selecting a patient reported outcome measure and assessing fatigue with patients  
To be able to target and evaluate interventions, it is important to measure fatigue with appropriate 
patient reported outcome measures (PROMs). PROMs can be used within consultations to screen for 
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problems, monitor symptoms over time, promote patient-centred care and to involve patients in 
decision making about their own treatment.45 In addition, they can be used as a discussion tool within 
a consultation to enhance communication between healthcare professionals and patients46 47(see 
section on Communication skills for health professionals).  
 
When selecting a tool to measure fatigue, healthcare professionals should consider whether they 
require a single item screening tool, a global score captured by a multi-item fatigue PROM or a 
multidimensional measure which captures scores for different fatigue domains, such as mental and 
physical fatigue.48 For example, if a multidimensional tool were to identify that physical fatigue is 
problematic for an individual but mental fatigue is less of an issue, this information could be used to 
individualise support on the basis of shared decision-making between the patient and the healthcare 
professional. Below are examples of fatigue PROMs used in clinical practice with patients who have 
IA. Some fatigue PROMs are disease specific, while others are generic. The psychometric properties 
are not fully explored here and not all the measures have been fully evaluated for all IA populations. 
In addition, it should also be noted that not all these PROMs are available in a range of European 
languages.  For detailed information, these measures have been critically evaluated by Hewlett et al.48 
 
Single Item Fatigue Measures 
Visual analogue scale (VAS)  
• A 10cm/100mm horizontal line which measures fatigue severity or intensity of fatigue. It can 
be used as a screening tool and to detect changes in fatigue over time and takes under one 
minute to complete. The wording used as end points or anchor statements can vary.  
 
The Bristol Rheumatoid Arthritis Numerical Rating Scales (revised) (BRAF-NRS V2)28 49 50 
• RA-specific measures containing three single item 0-10 numerical rating scales which capture 
fatigue severity, fatigue effect and fatigue coping. Each NRS takes under one minute to 
complete. 
 
Global Measures of Fatigue 
Fatigue Severity Scale (FSS)51 
• A nine-item measure which includes physical, social and cognitive effects of fatigue to provide 
a global score. The measure takes around 2-3 minutes to complete. 
 
Multi-dimensional Assessment of Fatigue (MAF)52-54 
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• A 16-item RA-specific PROM which covers four dimensions of fatigue (severity, distress, 
interference in activities of daily living and frequency) to provide a global score (Global Fatigue 
Index). The measure takes around 5-8 minutes to complete. 
 
Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F)55 
• A 13-item measure that provides a global score and takes around 2-4 minutes to complete.  
 
Short Form 36 Vitality Subscale (SF-36 VT)56 
• A subscale that forms part of the SF-36v2, a multi-dimensional measure of general health 
status. The SF-36 VT has four items covering energy and fatigue and the scores provides a 
single vitality score. The subscale takes a minute to complete. However, it is administered as 
part of the larger SF-36v2 which takes up to 10 minutes to complete. 
 
Multi-dimensional fatigue PROMs (generic) 
Chalder Fatigue Questionnaire (CFQ)57 
• An 11-item measure that provides a global fatigue score as well as two subscale scores 
(physical and mental fatigue). It takes around 2-3 minutes to complete. 
 
Multi-dimensional Fatigue Inventory (MFI)58 
• A 20-item measure that provides five sub-scale scores (general fatigue, physical fatigue, 
reduced activity, reduced motivation). It takes around 3-4 minutes to complete.  
 
Multi-dimensional fatigue PROMs (disease specific) 
Bristol Rheumatoid Arthritis Fatigue Multi-dimensional Questionnaire (BRAF-MDQ)28 49 50 
• A 20-item measure that provides a global fatigue score as well as four sub-scale scores 
(physical fatigue, living with fatigue, cognitive fatigue and emotional fatigue) and takes 4-5 
minutes to complete. 
 
The Profile of Fatigue and Discomfort (PROFAD)59 
• A measure designed for use in pSS. It comprises 16 items which measure aspects of fatigue. 
The scores from these items can be used to measure six facets of fatigue (need rest, poor 
starting, low stamina, weak muscles, poor concentration and poor memory). Domain scores 





Potential reversible causes of fatigue should be considered during assessment. This might include a 
review of medications which may be exacerbating fatigue symptoms or inducing daytime sleepiness.  
Other medical assessments and subsequent interventions should include identifying and treating 
comorbidities such as anaemia or metabolic and endocrine abnormalities, or other health conditions 
such as cancer or diabetes, as well as assessing for pain, sleep disturbances (including insomnia and 
obstructive sleep apnoea (OSA)), low mood and anxiety (see section on Other interventions that 
potentially impact fatigue). Some rheumatic diseases, including pSS are associated with dysregulation 
of the autonomic nervous system, including impaired blood pressure response to standing.60 
Autonomic dysfunction is associated with fatigue and addressing vasovagal symptoms either using 
purely a non-pharmacological approach, or a non-pharmacological approach in combination with 
medication, may help to improve the severity and impact of fatigue in these patients.61 62 
 
Social situation, family support and lifestyle assessment 
We recommend a general assessment of a patient’s social situation and daily function, including how 
their function may fluctuate according to their fatigue levels and other life demands. This assessment 
should include determining who they live with, expected roles within the household, what they need 
to do as part of their day, and determining whether they have had to take time off work or cancel 
other activities due to their fatigue. In addition, patients can be asked, in the context of living with 
their fatigue, how well they feel they are able to carry out their work, domestic tasks, self-care 
activities and leisure, including exercise and social activities. The Canadian Occupational Performance 
Measure is a semi-structured interview tool which is useful for exploring these areas.63 The balance of 
activities in a person’s life can be explored further with the Occupational Balance Questionnaire.64 
Reflections on the responses from these measures can be used when supporting a patient to set goals 
during treatment (see section on Non-pharmacological interventions to reduce fatigue: clinical 
practice). 
 
Sleep assessment  
Perhaps unsurprisingly, there is a relationship between sleep disturbances and fatigue in IA.65 66 
Therefore, addressing sleep disturbances may contribute to an improvement in fatigue.67 Primary 
sleep disorders, including OSA, require specialist assessment and care. Snoring and excessive daytime 
sleepiness can be an indication of OSA.68 Patients should be asked if they have any issues with snoring 
or struggling to breathe during the night. If possible and appropriate, it is useful to have a partner 
present when asking these questions. Daytime sleepiness can be measured with the Epworth 
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Sleepiness Scale (ESS),69 which can be used as a screening tool for primary sleep disorders including 
OSA.70 Any suspicion of a primary sleep disorder warrants a referral to a sleep specialist for further 
evaluation. A sleep diary can be a useful tool to identify symptoms of insomnia, and detect difficulties 
with sleep onset, night awakenings, sleep efficiency (percentage of time spent in bed asleep) and total 
sleep time.71  
 
Depression 
As depression is associated with fatigue, early recognition and intervention are essential.40 72 The 
Hospital Anxiety and Depression Scale is a useful 14-item tool which can be used to detect depression 
and anxiety in patients.73 If depression is detected during a fatigue assessment, appropriate 
management should be arranged in consultation with the patient and their clinical team. Some 
antidepressant medications are associated with side effects of drowsiness and fatigue and these 
possible side effects should be considered during assessment or by members of the clinical team who 
may be considering a pharmacological intervention for low mood.  
 
Pain 
Pain is a dominant feature of IA74 and is associated with fatigue in RA,75 SLE,76 77 pSS,40 78 and AS.79 
Supporting a patient with managing their pain may therefore have a positive impact on their fatigue. 
A discussion with the patient to identify whether they perceive a relationship between these 
symptoms may be helpful when developing a management plan. It is also worth considering any 
drowsy side effects of pain management medication. 
 
Non-pharmacological interventions to reduce fatigue: the evidence base 
To address the potentially complex and multifactorial nature of fatigue, it is likely that a 
multidimensional approach incorporating pharmacological and non-pharmacological interventions is 
the best management strategy.80 81 Psychosocial interventions, such as self-management 
programmes, cognitive-behavioural approaches and lifestyle interventions, or interventions based on 
physical activity have all been proposed as potentially beneficial.19 82-84 A Cochrane review83 evaluated 
the benefits and harms of non-pharmacological interventions for the management of fatigue, 
specifically in adults with RA.  The majority of the 24 included studies investigated physical activity 
interventions (n=6) or psychosocial interventions (n=13) with meta-analyses demonstrating 
statistically significant small beneficial effects on fatigue for both intervention categories. In terms of 
quality, the physical activity evidence was moderate and the studies investigating psychosocial 
interventions were considered low quality.  A key recommendation from the review was the need to 
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design interventions specifically for fatigue management.  A more recent systematic review 
investigating the effects of land based aerobic training on RA fatigue reported similar findings.85 So 
far, research investigating non-pharmacological interventions for fatigue management in people with 
IA has focussed mainly on physical activity and psychosocial approaches. A few other non-
pharmacological interventions have been investigated with variable effects on fatigue.  The following 
provides a summary of recent evidence within each of these non-pharmacological categories. 
 
Physical activity interventions 
For people with RA, Durcan et al. investigated a 12-week home exercise plan that was individualised 
to target functional limitations identified by the participant.86 The exercise plan included resistance 
exercise undertaken three times per week as well as range of movement and light to moderate 
intensity walking undertaken daily.  The control arm received standard care only.  Results 
demonstrated significant between group differences in change of fatigue at 12-weeks in favour of the 
intervention. 
 
A 16-week supervised walking programme for women with primary pSS was compared to a control 
arm that were advised not to undertake any regular exercise.87  The walking intervention consisted of 
three supervised sessions per week with increasing duration.  There was a significant difference 
between study arms over time for fatigue, in favour of the intervention arm.  This supported earlier 
pilot study findings in which women with pSS undertook Nordic walking three times per week for 45 
minutes with one of the three sessions supervised.88  In comparison to a control arm that was 
instructed to carry out low intensity exercise at home, the intervention group demonstrated a 
significant improvement in fatigue at 12 weeks, as measured using a VAS. 
 
For those with SpA, Sveaas et al. investigated a 12-week high intensity aerobic and strength training 
programme.81 Participants in the exercise arm carried out twice weekly supervised high intensity 
aerobic interval training and strength exercises as well as once weekly unsupervised aerobic training.  
In comparison to the control arm that received standard care there was a significant treatment effect 
for fatigue in favour of the intervention.  Another recent pilot study in people with axial SpA 
investigated the effect of Baduanjin qigong (exercise techniques that alternate relaxed movement 
with stretching and strengthening) in comparison to a control arm.89 Findings demonstrated clear 
trends for improvement in fatigue in the exercise arm compared to a control arm, suggesting that 




Taken together these studies indicate that a wide range of moderate and high intensity physical 
activity interventions can produce short term benefit for fatigue in a range of IA conditions.  None of 
the studies mentioned above included a health behaviour change component to promote long term 
engagement with the activities and no long term follow up measures were reported.  It should also be 
noted that while fatigue was included as an outcome, there was no reference to fatigue mechanisms 
in the design or implementation of the interventions at an individual level.   
 
Additional studies that have investigated the effect of a physical activity intervention with a supporting 
health behaviour change component include Thomsen et al. in which individual counselling and SMS 
reminders (texts) aimed to reduce daily sitting time in people with RA.90 At the end of the 16-week 
intervention there was a significant improvement in fatigue in the intervention arm compared to the 
usual care control arm.  It is possible that an intervention to reduce daily sitting time would be more 
acceptable to people experiencing fatigue than an intensive home exercise programme and as a result 
more likely to be sustained long term.  However, further research with long term follow up is required 
to explore this possibility.   
 
A pedometer intervention that aimed to increase physical activity by people with RA was investigated 
by Katz et al.91  One arm received the pedometer with daily step count goals and a second arm received 
the pedometer with no specified goals.  This was in addition to a control arm that did not receive a 
pedometer.  At the end of the 21-week intervention period there was a reduction in fatigue in the 
pedometer and pedometer plus step count arms, but this was not significantly different to the control 
arm. It should be noted however, that the target sample size was not reached which could explain the 
lack of significant effect. 
 
Feldthusen et al. investigated a person-centred physical therapy intervention for people with RA that 
focused on health enhancing physical activity and balancing life activities.92  They suggested that this 
approach could strengthen confidence and resources to control fatigue as well as condition related 
symptoms associated with fatigue.  There was a significant improvement in fatigue at the end of the 
12-week intervention compared to the control arm which remained significant at six months. 
 
Psychosocial interventions 
In relation to the psychosocial interventions, most of the research evidence is specific to RA.  A recent 
study by Hewlett et al. investigated the effect of a six-week group course delivered by rheumatology 
teams using cognitive behavioural approaches on fatigue impact.93  The intervention aimed to address 
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‘behaviours likely to be related to fatigue and their underpinning thoughts and feelings’.  There was a 
significant reduction in fatigue impact at six months in the ‘Reducing Arthritis Fatigue’ intervention 
arm compared to the control arm.  This difference remained significant at the two year follow up time 
point.   
 
Ferwerda et al. also recruited people with RA to complete at least one of four internet-based cognitive 
behavioural intervention modules with fatigue being the focus of one module.94  Not all participants 
completed the fatigue module and despite fatigue being identified as a joint primary outcome, the 
overall purpose of the intervention appeared to be reduction of distress. At one-year follow-up, there 
was a non-significant reduction in fatigue over time for the internet-based cognitive behavioural 
intervention arm compared to the control arm.  However, it should be noted that only 37 of the 62 
participants in the intervention arm completed the internet-based fatigue module.   
 
While recent studies have focussed on cognitive behavioural approaches, earlier studies have 
suggested benefits of other approaches for the management of fatigue in people with RA.  Those 
indicating the largest effects for fatigue include benefit finding and expressive writing interventions,95 
lifestyle management,96 and a mindfulness-based group intervention.97 
 
Other non-pharmacological interventions  
Gok Metin & Ozdemir  investigated an aromatherapy intervention and a reflexology intervention for 
people with RA.98  For aromatherapy, the oils were included on the basis of their active ingredients 
and proposed physiological effects. Results showed a significant reduction in fatigue over time for 
both intervention arms compared to the control arm, with the reflexology arm demonstrating greater 
reduction that the aromatherapy arm. However, there were some limitations to this study including a 
lack of assessor blinding, the absence of a long term follow up, and no active control arm. Therefore, 
further research is necessary before aromatherapy or reflexology can be recommended as an 
intervention for fatigue in adults with RA. Other non-pharmacological interventions that have shown 
some promise and are worthy of further investigation include adoption of a Mediterranean diet,99 
Omega-3 fatty acid supplementation for people with RA,100 and vagus nerve stimulation for people 
with pSS.101 
 
We established earlier in the paper that fatigue is a complex and multidimensional symptom that is 
likely to be driven by a range of factors that vary between individuals. In addition, the evidence 
suggests that psychosocial factors play a role in many people’s fatigue. Therefore, people with IA may 
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benefit from interventions that target factors such as pain, poor sleep and depression. Earlier we 
discussed assessment, and later we will consider how factors such as sleep and depression can be 
addressed in clinical practice. Here, we describe the evidence for some potentially helpful non-
pharmacological interventions.   
 
Cognitive behaviour therapy for insomnia (CBT-I) may be a useful intervention for people with co-
morbid insomnia and IA and there is some evidence for its effectiveness at improving insomnia 
symptoms in other rheumatological conditions including OA and fibromyalgia (FMS).102 103 A CBT-I 
intervention comprises of several key components, which are usually delivered over 6-8 sessions by a 
trained therapist who receives the appropriate supervision.  Components include sleep education and 
sleep hygiene; sleep restriction; stimulus control; cognitive control; thought control/distraction; 
paradoxical intention and dealing with dysfunctional beliefs/cognitive restructuring. 104 105  
 
Depression is common in rheumatic diseases.106-108 It is important that health professionals are able 
to identify signs of depression and low mood, and that those affected are able to access appropriate 
interventions.109 110 Some components of recommended treatments for depression, such as 
behavioural activation (e.g. identifying valued life activities and goal setting) and cognitive behavioural 
therapy (e.g. graded activity), are like those offered for fatigue management.111 Therefore, it is 
possible that an intervention that includes some components of an evidence-based psychosocial 
intervention for depression, may have a positive impact on a person’s fatigue. However, this cannot 
be assumed.  
 
Pain management strategies should follow the appropriate guidelines and may include 
pharmacological and non-pharmacological interventions. Some of the recommended non-
pharmacological interventions for pain in arthritis74 share similarities with fatigue management 
strategies (e.g. activity pacing).112 Therefore, some non-pharmacological fatigue management 
strategies may help with pain management and vice versa. Health professionals might also be able to 
transfer their training and skills between supporting pain and fatigue management.  
 
The ethos of non-pharmacological interventions to reduce fatigue 
Overall, evidence suggests that non-pharmacological interventions can have a beneficial effect on self-
reported fatigue in people with IA. Key to successful multi-disciplinary non-pharmacological 
interventions is empowering patients to self-manage their health condition, with a view to improving 
symptom control, preventing long-term complications and developing coping strategies. In the UK, 
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the National Health Service (NHS) Five-Year Forward view recognises “that patients' own life goals are 
what counts” and individuals need to be empowered to manage their own conditions.113 It is 
increasingly acknowledged that effective health professional–patient partnerships involve shared 
decision-making and self-management interventions to deliver better outcomes and improved quality 
of life with potential cost savings across the health and care system.114 However, to successfully 
manage their health, people need information and tools to develop and maintain self-management 
skills.115 116 One potential area to explore is the role of mobile technology, such as pedometers and 
web-based applications.113 Incorporating technology could increase benefits and help scale up delivery 
of self-management tools to meet the health needs of those with IA and reduce pressure on services.  
 
Non-pharmacological interventions to reduce fatigue: clinical practice 
The first step to providing support in clinical practice is identifying that fatigue is an issue for someone 
and being open to working with them on management strategies.109 While fatigue is a common and 
debilitating symptom for many people with IA, they can be reluctant to discuss their fatigue during 
their clinic appointments, as there is a perception that this symptom will be dismissed by their 
healthcare professionals.24 The failure of healthcare professionals to acknowledge fatigue and its 
impact on daily life can exacerbate any psychological distress and impact on patients’ confidence.117 
Findings from a Dutch study demonstrated that patients may use implicit cues about their fatigue 
during a consultation, rather than being explicit about their concerns.18 Having the symptom of fatigue 
taken seriously, being believed and having appropriate support to self-manage this symptom are top 
priorities for patients.118 A UK multicentre survey investigating patient preferences for psychological 
support in IA found that 82% of patients wanted support with managing the impact of both pain and 
fatigue,119 which suggests that this need is currently not being addressed. It is therefore important for 
healthcare professionals to ask patients about fatigue directly during consultations, rather than 
putting the onus on the patient to spontaneously mention it.18 
 
Techniques and tools for clinical practice  
It is important for members of the rheumatology team to validate and acknowledge patients’ 
experience of fatigue and the impact that this symptom has on their lives. A qualitative study which 
explored the impact of written information about fatigue using an education booklet, concluded that 
written information that was provided by a health professional and followed by a conversation which 
included some guided reflection, was sufficient for some patients to make behaviour changes to help 




Communication skills for health professionals  
The interaction between health professionals and patients can play a key role in the provision of 
fatigue support.121 A collaborative dynamic that values both professional expertise and lay experiential 
knowledge can help patients to acquire the information and skills that they need to actively manage 
their health.122 Approaches such as motivational interviewing (MI) and Socratic questioning (also 
known as guided discovery or ‘Ask don’t tell’) can be helpful and have been used in psychosocial 
interventions for RA-related fatigue.26 82 93 MI is an evidence-based way to discuss behaviour change 
that promotes patients’ autonomy and decision-making.123 The focus is on eliciting patients’ thoughts 
and feelings about behaviour change and guiding discussions to resolve their ambivalence. A key tool 
is the use of ‘OARS’ questions (open-ended, affirmations, reflections, and summaries).124 Likewise, 
Socratic questions are curious and non-judgemental (e.g. ‘How is this a problem for you? Can you give 
me an example?) and designed to explore assumptions (e.g. ‘Let me check that I understand this’). 
These are questions that the patient has the answers to, that draw attention to relevant issues and 
information, that move from concrete to abstract, and that help the patient learn to reflect.125 126  
 
Activity diaries  
Due to the unpredictable nature of RA fatigue, monitoring tools can be helpful. One example is an 
activity diary to monitor energy expenditure. Patients can use the diary to record their activity levels, 
rest, sleep and to make a note of any fatigue “crashes” when any activity had to stop due to 
overwhelming fatigue. The completed diary can then be used with a health professional in a guided 
reflection to look for patterns in activity levels and fatigue symptoms and to identify behaviours that 
might be driving or exacerbating crashes. This tool can also be used to prospectively plan, for example 
allocating times for rest as part of pacing activity during the week. Activity diaries are used in fatigue 
self-management interventions and have been highlighted by patients as helpful for self-
management.26 82 93  
 
Problem solving 
Completing a daily activity diary can help patients analyse how they do activities. As an example, if a 
person spends every morning doing the same activity, repetitive task, or in the same working position, 
they might spend the afternoons dealing with an exacerbation of pain and discomfort as a result. A 
patient can be supported to consider the following question, “When a task or an activity causes a 
problem, how might you be able to do it differently?”. The activity diary can show patterns in boom 
and bust behaviours (e.g. weekends spent recovering from a working week, or ‘crash’ periods after a 




Patients can break up an activity into smaller, bite-sized chunks, spreading them out over a period and 
interspersing them with short, regular rests. For example, rather than tackling a cleaning task in one 
go (such as the entire home), it can be divided up into zones (such as rooms) or smaller tasks (such as 
dusting) and one zone or task completed before taking a break. Activities can also be paced over a 
longer period, such as a week, and interspersed with different types of activity and rest. It is helpful 
for patients understand the importance of taking a break before the fatigue sets in.  
 
Prioritising 
Patients can write down tasks and activities that need to be done in a day or a week and rank them 
for importance. Patients can decide whether each task needs to be done, whether it can be delegated 
or whether someone can help with it. One challenge when patients prioritise is that tasks which could 
be viewed as less important, may be tasks which are meaningful and fulfilling. For example, patients 
may prioritise work or looking after family members above their own leisure activities. It can then be 
helpful to have exploratory discussions about the choices that the patient makes and whether they 




Patients can use the prioritised task list and a blank activity diary to plan activity over the next week 
or few days. By using a combination of problem solving, pacing techniques and prioritising, patients 
can plan for essential tasks to be interspersed with regular planned rests and leisure activities. 
 
Goal setting 
Supporting patients to set goals as part of shared decision making can be a useful part of fatigue 
management. One approach is SMART (specific, measurable, achievable, realistic, and timely/time 
limited), which can be helpful for goals that relate to task completion and behaviour.126 However, if 
the goals concern knowledge, skills, abilities and strategies which focus on learning, a MEANING 
approach may be more appropriate.127 Goals should be meaningful (M), health professionals should 
engage (E) patients to establish trust and discuss what is meaningful, short term goals should be 
anchored (A) to what is meaningful and to the interventions to reach long term goals, patients and 
health professionals should negotiate (N) the desired level to aim for and create motivation and hope. 
Patients and health professionals should try to bridge the intention-implementation (I) gap and 
consequently, setting new goals (N) should be an on-going process which provides an opportunity for 
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patients to develop a strategy and to learn over time. Finally, goals (G) should relate to theoretically 
informed behaviour change. The Canadian Occupational Performance Measure is a semi-structured 
qualitative interview tool which can also be useful to help patients identify short and long-term goals 
in these separate areas to introduce some occupational balance.63 128  
 
Grading activity 
This is when a patient selects an activity which they would like to do more of, or to re-introduce if they 
have been stopped due to their fatigue (see goal setting). Activities can be graded up in time, 
effort/resistance, complexity and speed. However, any chosen activity should be graded up gradually 
and maintained before another increase is made. For example, if a patient can concentrate on reading 
for 15 minutes without exacerbating their symptoms, they may like to try and extend this by a couple 
of minutes.  
 
Physical Activity 
Being physically active can help to reduce fatigue although it can be difficult to get started.  It is 
important to start with small, achievable activity targets with short bouts of moderate physical 
activity.  There is no clear evidence for one type of activity being better at reducing fatigue although 
finding something that the person enjoys is important. It may also help to have an exercise buddy to 
help with motivation.129  Over time gradually increase the duration and/or intensity of the activity as 
it becomes easier.  During periods of flare or illness, or if fatigue is exacerbated by the activity, it may 
be necessary to drop back to a previous level.  This should not be viewed negatively and when possible 
continue to progress the activity again. 
 
Assertiveness and communication training for patients  
Fatigue is an invisible symptom. Therefore, it is essential for someone with fatigue to be able to 
communicate their needs appropriately.126 Education on different communication styles, for example 
being assertive as opposed to being manipulative, passive or aggressive, can help someone to 
communicate their needs appropriately. Similarly, being able to “say no” is a useful skill, which can 
help prevent patients from feeling overwhelmed, upset or exhausted from taking on too much. 
Supporting patients to reflect on their assertiveness and communication skills can include discussions 





Stress and bodily reactions to stressors can negatively affect patients’ physical and mental fatigue. 
Mindfulness is an approach which has been used primarily for stress-reduction. It is a technique where 
the person brings their awareness to what is going on in the present moment, including their bodily 
sensations and reactions, without being judgemental.97 130 131 The practice of mindful meditation 
cultivates attentional focus and stability by directing the mind to remain connected to the experience 
of the present moment. Attention is usually sustained by concentrating on the breath.  
 
Setback planning 
Accepting that setbacks and fatigue flares are likely to happen can be a positive step for a person with 
IA, and advance planning on how to deal with these situations can be helpful. Being aware of triggers 
that can cause a setback (such as a flare of symptoms, viral illness, stress, deadlines, periods of over-
activity, and other life events) can help a person anticipate when a setback might be likely to happen. 
However, it is important to recognise that setbacks can also occur without any obvious reason. It may 
be useful to work with “if – then” to try to reduce the intention-implementation gap. This can be “if 
your child is sick and you cannot exercise as planned that day, then …”.127 Whatever the trigger, if a 
person with IA has a plan in place, it can help them to deal with the challenge proactively. The plan 
may vary depending on the trigger, for example, a viral illness may require a few days of rest. A plan 
may include reducing exercise and increasing the use of relaxation for a period. It may also be helpful 
to use some of the previously mentioned strategies; e.g. keep an activity diary for a short period and 
use it to plan a new schedule with planned rests.  
 
Workplace considerations 
Fatigue has been found to have a significant and independent effect on absenteeism, presenteeism, 
productivity loss, and activity impairment.33 Reasonable adjustments can be made in the workplace 
to manage the fatigue associated with IA and will need the patient to discuss their requirements with 
their occupational health department and their manager. A clinical intervention can include a letter 
of support outlining some suggestions for reasonable adjustments. This could include flexible start 
and finish times, working from home, regular breaks, the ability to switch tasks and appropriate 
seating. Discussions about joint protection and ergonomics may also be helpful.34 132  
 
Conclusions 
In summary, research evidence and clinical practice have established that fatigue is a common 
symptom affecting many people with IA. It can impact all realms of daily life, including relationships, 
work, social activities and emotional well-being. The causes of fatigue in IA remain unclear, although 
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there is growing consensus that it is likely to be multidimensional and driven and maintained by 
several factors that differ between and within individuals over time. Currently, the strongest evidence 
is for the role of psychosocial factors. While limitations remain in relation to the evidence to support 
the use of non-pharmacological interventions in the management of IA-related fatigue, they have the 
potential to benefit people with IA. In relation to psychosocial interventions, there is evidence that 
cognitive behavioural approaches can reduce the impact of RA fatigue, while for physical activity there 
is strong evidence of short-term benefit with further research needed to explore long term effects. A 
range of helpful approaches and tools are available for health professionals to use in clinical practice. 
The first step is to identify and assess a person’s fatigue, then to look at ways to support them to 
develop management strategies. This might involve targeting fatigue directly or looking at other 
related factors such as poor sleep, pain and depression. There is evidence to support the use of a 
Socratic questioning or ‘Ask don’t tell’ approach and using cognitive behavioural tools such as activity 
diaries, and for promoting the benefits of physical activity. Fatigue support should be based on a 
collaborative approach between health professionals and patients, with the aim of empowering 
patients to feel more in control of their IA and equipped to cope with the challenges of an 
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